Concurrent Investment Advisors, LLC Charles River Laboratories International, Inc. Transaction History
Concurrent Investment Advisors, LLC
- $4.12 Trillion
- Q1 2025
A detailed history of Concurrent Investment Advisors, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Concurrent Investment Advisors, LLC holds 1,412 shares of CRL stock, worth $167,491. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,412Holding current value
$167,491% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
697Shares Held
50.4MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$731 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$604 Million0.02% of portfolio
-
State Street Corp Boston, MA2.18MShares$259 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.81MShares$214 Million0.79% of portfolio
-
Allspring Global Investments Holdings, LLC1.77MShares$211 Million0.5% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $6.03B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...